These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25090595)

  • 1. The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy.
    Mortensen NP; Durham P; Hickey AJ
    J Microencapsul; 2014; 31(8):785-95. PubMed ID: 25090595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state.
    Gad S; Tajber L; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray Dried Aerosol Particles of Pyrazinoic Acid Salts for Tuberculosis Therapy. [Corrected].
    Durham PG; Zhang Y; German N; Mortensen N; Dhillon J; Mitchison DA; Fourie PB; Hickey AJ
    Mol Pharm; 2015 Aug; 12(8):2574-81. PubMed ID: 26098136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitubercular inhaled therapy: opportunities, progress and challenges.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2005 Apr; 55(4):430-5. PubMed ID: 15761077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate pulmonary delivery systems containing anti-tuberculosis agents.
    Gupta A; Pandya SM; Mohammad I; Agrawal AK; Mohan M; Misra A
    Crit Rev Ther Drug Carrier Syst; 2013; 30(4):277-91. PubMed ID: 23662603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of nanoparticles by spray-drying and their use for efficient pulmonary drug delivery.
    Li HY; Zhang F
    Methods Mol Biol; 2012; 906():295-301. PubMed ID: 22791442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
    Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary drug delivery systems for tuberculosis treatment.
    Pham DD; Fattal E; Tsapis N
    Int J Pharm; 2015 Jan; 478(2):517-29. PubMed ID: 25499020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of different vitamin E carriers intended for pulmonary drug delivery.
    Laouini A; Andrieu V; Vecellio L; Fessi H; Charcosset C
    Int J Pharm; 2014 Aug; 471(1-2):385-90. PubMed ID: 24939617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes as drug delivery systems for the treatment of TB.
    Pinheiro M; Lúcio M; Lima JL; Reis S
    Nanomedicine (Lond); 2011 Oct; 6(8):1413-28. PubMed ID: 22026379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
    Manca ML; Cassano R; Valenti D; Trombino S; Ferrarelli T; Picci N; Fadda AM; Manconi M
    J Pharm Pharmacol; 2013 Sep; 65(9):1302-11. PubMed ID: 23927468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray drying from organic solvents to prepare nanoporous/nanoparticulate microparticles of protein: excipient composites designed for oral inhalation.
    Ní Ógáin O; Tajber L; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2012 Sep; 64(9):1275-90. PubMed ID: 22881440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis.
    Chae J; Choi Y; Tanaka M; Choi J
    J Biosci Bioeng; 2021 Dec; 132(6):543-551. PubMed ID: 34538591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model.
    Garcia-Contreras L; Fiegel J; Telko MJ; Elbert K; Hawi A; Thomas M; VerBerkmoes J; Germishuizen WA; Fourie PB; Hickey AJ; Edwards D
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2830-6. PubMed ID: 17517845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled drug therapy for treatment of tuberculosis.
    Misra A; Hickey AJ; Rossi C; Borchard G; Terada H; Makino K; Fourie PB; Colombo P
    Tuberculosis (Edinb); 2011 Jan; 91(1):71-81. PubMed ID: 20875771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effect from indomethacin nanoparticles inhaled by male mice.
    Onischuk AA; Tolstikova TG; Sorokina IV; Zhukova NA; Baklanov AM; Karasev VV; Dultseva GG; Boldyrev VV; Fomin VM
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):231-43. PubMed ID: 18627274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.